Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-10 Sale | 2024-12-11 6:44 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 8,273 | $50 | $413,650 | 2,760,317 (Indirect Direct) | View |
| 2024-10-10 Sale | 2024-10-11 4:48 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 7,465 | $52.76 | $393,853 | 92,301 (Direct) | View |
| 2024-09-03 Sale | 2024-09-05 11:53 am | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $55.85 | $1,117,000 | 2,788,582 (Indirect Direct) | View |
| 2024-09-03 Sale | 2024-09-05 11:50 am | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 91 | $56.19 | $5,113 | 41,551 (Direct) | View |
| 2024-08-06 Sale | 2024-08-07 2:48 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $50.17 | $1,003,400 | 2,808,582 (Indirect Direct) | View |
| 2024-07-02 Sale | 2024-07-03 2:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 584 | $40.98 | $23,932 | 12,009 (Direct) | View |
| 2024-06-12 Sale | 2024-06-12 7:47 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 9,806 | $45 | $441,270 | 57,981 (Direct) | View |
| 2024-06-10 Sale | 2024-06-10 7:58 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 1,737 | $41.1 | $71,391 | 7,248 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 3:23 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 354 | $43.66 | $15,456 | 48,431 (Direct) | View |
| 2024-04-18 Sale | 2024-04-19 4:35 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 142 | $44.1 | $6,262 | 48,785 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 1:41 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 11,509 | $49.93 | $574,644 | 252,823 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 12:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 12,195 | $50.88 | $620,443 | 14,860 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,756 | $53.76 | $201,923 | 98,740 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:19 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 1,011 | $53.76 | $54,351 | 295,732 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 4,173 | $53.76 | $224,340 | 120,668 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:13 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 341 | $53.76 | $18,332 | 51,931 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 1,238 | $53.76 | $66,555 | 85,478 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 4,768 | $53.76 | $256,328 | 101,363 (Direct) | View |
| 2024-02-07 Sale | 2024-02-08 3:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $45 | $1,350,000 | 2,803,755 (Indirect Direct) | View |
| 2023-12-29 Sale | 2024-01-02 4:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $47.87 | $1,436,100 | 2,833,755 (Indirect Direct) | View |
| 2023-10-23 Sale | 2023-10-24 5:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $32.78 | $1,307,201 | 246,860 (Direct) | View |
| 2023-10-19 Sale | 2023-10-23 5:14 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $33.52 | $1,604,033 | 2,863,728 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-10 Gift | 2024-12-11 6:47 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 648 | $0 | 41,840 (Direct) | View |
| 2024-12-09 Gift | 2024-12-11 6:44 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 20,000 | $0 | 2,760,317 (Indirect) | View |
| 2024-09-16 Option Award | 2024-09-18 1:03 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 700 | $0 | 42,251 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:29 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 15,245 | $0 | 34,975 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:26 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 15,245 | $0 | 30,105 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:25 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director | 15,245 | $0 | 36,850 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:24 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director | 15,245 | $0 | 36,850 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:23 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director | 15,245 | $0 | 27,525 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:22 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 15,245 | $0 | 22,493 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:22 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 15,245 | $0 | 30,100 (Direct) | View |
| 2024-04-16 Tax Withholding | 2024-04-18 6:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 14 | $42.31 | 41,366 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:23 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 53,600 | $0 | 133,966 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:22 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 50,157 | $0 | 98,740 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:19 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 274 | $53.69 | 295,732 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:19 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 50,157 | $0 | 295,732 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:17 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 470 | $53.69 | 114,402 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:17 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 50,157 | $0 | 114,402 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:15 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 60 | $53.69 | 120,668 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:15 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 50,157 | $0 | 120,668 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:13 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 121 | $53.69 | 51,931 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:13 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 24,501 | $0 | 51,931 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:10 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 55,951 | $0 | 85,478 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:08 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 54,557 | $0 | 101,363 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 17,417 | $53.69 | 2,897,992 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:06 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 111,654 | $0 | 2,897,992 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 4:06 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $0 | 27,892 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 4:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $21 | 27,892 (Direct) | View |
| 2023-12-20 Option Award | 2024-01-02 4:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 1,000 | $0 | 27,892 (Direct) | View |
| 2023-10-23 Exercise | 2023-10-24 5:22 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $6.86 | 246,860 (Direct) | View |
| 2023-10-23 Exercise | 2023-10-24 5:22 pm | N/A 2023-10-31 | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $0 | 246,860 (Direct) | View |
| 2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $6.86 | 2,863,728 (Direct) | View |
| 2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A 2023-11-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $0 | 2,863,728 (Direct) | View |
| 2023-10-09 Option Award | 2023-10-10 12:50 pm | N/A 2033-10-09 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 220,835 | $0 | 220,805 (Direct) | View |
| 2023-09-27 Option Award | 2023-09-29 2:16 pm | N/A 2027-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,351 | $0 | 25,965 (Direct) | View |
| 2023-09-27 Option Award | 2023-09-29 2:15 pm | N/A 2027-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 2,351 | $0 | 32,863 (Direct) | View |